Company Filing History:
Years Active: 2012
Title: John King-Underwood: Innovator in Heterocyclic Derivatives
Introduction
John King-Underwood is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. His work focuses on addressing critical health issues such as obesity and diabetes.
Latest Patents
John King-Underwood holds a patent for "Heterocyclic derivatives as GPCR receptor agonists." This patent describes compounds of Formula (I), R-A-V—B—R, or pharmaceutically acceptable salts thereof, which act as agonists of GPR116. These compounds are particularly useful as regulators of satiety, making them valuable in the treatment of obesity and diabetes.
Career Highlights
Throughout his career, John has demonstrated a commitment to innovation in the pharmaceutical industry. His work at Prosidion Limited has positioned him as a key player in the development of new therapeutic agents. His research has the potential to impact the lives of many individuals struggling with metabolic disorders.
Collaborations
John collaborates with talented professionals in his field, including Matthew Colin Thor Fyfe and Lisa Sarah Gardner. These partnerships enhance the research and development efforts at Prosidion Limited, fostering an environment of innovation and discovery.
Conclusion
John King-Underwood's contributions to the field of pharmaceuticals, particularly through his patent on heterocyclic derivatives, highlight his role as an innovator. His work continues to pave the way for advancements in treatments for obesity and diabetes.